Home › Funds › Allied Investment Advisors, LLC › ABT

Allied Investment Advisors, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Allied Investment Advisors, LLC reported holding 129,788 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$12.8M, representing 1.21% of its reported portfolio and ranking #35 among its reported holdings. Allied Investment Advisors, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)129.79K sh
Reported value held$12.83M
Portfolio Weight1.21%
First reportedQ3 2023
Last changeAdd
Updated2026-10-14

Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR

How Allied Investment Advisors, LLC's ABT position evolved

Allied Investment Advisors, LLC first disclosed a stake in ABT in Q3 2023 at 74,263 shares (US$7.2M). The position peaked in Q3 2026 at 129,788 shares, worth US$12.8M. Across 13 filings, Allied Investment Advisors, LLC increased the stake 11 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 129,788 shares valued at US$12.8M — an increase of 6,707 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 74.26K $7.19M New
Q4 2023 75.74K $8.34M Add
Q1 2024 79.58K $9.05M Add
Q2 2024 82.52K $8.57M Add
Q3 2024 84.74K $9.66M Add
Q4 2024 86.58K $9.79M Add
Q1 2025 90.07K $11.95M Add
Q2 2025 89.65K $12.19M Hold
Q3 2025 94.60K $12.67M Add
Q4 2025 98.03K $12.28M Add
Q1 2026 105.32K $10.81M Add
Q2 2026 123.08K $11.17M Add
Q3 2026 129.79K $12.83M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Allied Investment Advisors, LLC held ABT?

Allied Investment Advisors, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Allied Investment Advisors, LLC's current position in ABT?

As of Q3 2026, Allied Investment Advisors, LLC holds 129.79K shares of ABT (ABBOTT LABORATORIES), valued at $12.83M, representing 1.21% of its reported portfolio and ranking #35.

Has Allied Investment Advisors, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Allied Investment Advisors, LLC increased its position in ABT. The position peaked in Q3 2026 at 129.79K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.